Roy Galvin is President, Global Plasma & BC of HAEMONETICS CORP. Currently has a direct ownership of 7,410 shares of HAE, which is worth approximately $623,403. The most recent transaction as insider was on May 17, 2024, when has been sold 2,872 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.41K
61.26% 3M change
58.03% 12M change
Total Value Held $623,403

Roy Galvin Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2024
BUY
Grant, award, or other acquisition
-
2,872 Added 27.93%
7,410 Common Stock
May 15 2024
SELL
Payment of exercise price or tax liability
$20,648 $96.49 p/Share
214 Reduced 4.5%
4,538 Common Stock
Nov 01 2023
SELL
Payment of exercise price or tax liability
$13,822 $86.39 p/Share
160 Reduced 3.36%
4,595 Common Stock
May 15 2023
BUY
Grant, award, or other acquisition
-
2,243 Added 32.36%
4,689 Common Stock
Nov 01 2022
BUY
Grant, award, or other acquisition
-
2,382 Added 50.0%
2,382 Common Stock
RG

Roy Galvin

President, Global Plasma & BC
Boston, MA

Track Institutional and Insider Activities on HAE

Follow HAEMONETICS CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HAE shares.

Notify only if

Insider Trading

Get notified when an Haemonetics Corp insider buys or sells HAE shares.

Notify only if

News

Receive news related to HAEMONETICS CORP

Track Activities on HAE